These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29791106)

  • 1. [EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.].
    Popova EP; Fisenko VP
    Eksp Klin Farmakol; 2016; 79(11):26-34. PubMed ID: 29791106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic action of beta-blockers: potential mechanisms.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antiarrhythmic drug effects by beta-adrenergic sympathetic stimulation.
    Sager PT
    Am J Cardiol; 1998 Aug; 82(4A):20I-30I. PubMed ID: 9737651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic properties of beta-blockers.
    Haverkamp W; Hindricks G; Gülker H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-infarction sustained ventricular tachycardias. The role of drugs and methods for assessing antiarrhythmic efficacy.
    Campbell RW
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():33-6. PubMed ID: 8734162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ventricular anti-arrhythmic treatments during postinfarction].
    Frank R; Tonet J; Lascault G; Fontaine G
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1725-9. PubMed ID: 1363903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Kishchuk EP
    Eksp Klin Farmakol; 2001; 64(1):33-7. PubMed ID: 11544801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic actions of growth hormone during acute myocardial infarction.
    Elaiopoulos DA; Kolettis TM
    J Electrocardiol; 2009; 42(3):298-9. PubMed ID: 19100564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genesis of glycoside poisoning in myocardial infarct and its rational pharmacoprevention].
    Gendenshteĭn EI; Sernov LN
    Kardiologiia; 1984 Dec; 24(12):117-21. PubMed ID: 6151609
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic action of adrenergic beta-receptor blocking agents.
    Seth SD
    Pharmacol Ther; 1980; 11(1):159-79. PubMed ID: 6107939
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.
    Podrid PJ; Fuchs T; Candinas R
    Circulation; 1990 Aug; 82(2 Suppl):I103-13. PubMed ID: 1973640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I and III antiarrhythmic drugs for prevention of sudden cardiac death and management of postmyocardial infarction arrhythmias. A review.
    Vrana M; Pokorny J; Marcian P; Fejfar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):114-24. PubMed ID: 23681306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.